Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-05-03

FDA Approved: LITHIUM CARBONATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

The FDA approved a supplemental application for lithium carbonate filed by Glenmark Pharmaceuticals Inc., USA, authorizing changes to the product's labeling und…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lithium carbonate (Lithium carbonate)

Snippet

SUPPL AP for LITHIUM CARBONATE (LITHIUM CARBONATE)